Cardiovascular and gross behavioral effects of amphetamine, 2-amino-1-(2,5-dimethoxy-4-methylphenyl) propane (DOM) and 2-amino-1-(2,5-dimethoxy-4-methylphenyl) butane (BL-3912A) in the conscious dog.
D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine / Q000494:pharmacology / Q000031:analogs & derivatives; D000661:Amphetamine / Q000494:pharmacology*; D000758:Anesthesia; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects; D002082:Butylamines / Q000494:pharmacology; D004285:Dogs; D004305:Dose-Response Relationship, Drug; D006213:Hallucinogens / Q000494:pharmacology*; D006339:Heart Rate / Q000187:drug effects; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D008738:Methyl Ethers / Q000494:pharmacology; D010627:Phenethylamines / Q000494:pharmacology*; D013239:Stereotyped Behavior / Q000187:drug effects; D013268:Stimulation, Chemical
D002082:Butylamines; D006213:Hallucinogens; D008738:Methyl Ethers; D010627:Phenethylamines; C006179:dimoxamine; D004290:DOM 2,5-Dimethoxy-4-Methylamphetamine; D000661:Amphetamine